United States · Series B startup

Who invested in Human Longevity

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Valuation: $1.0B, Oct 2024

Funding summaryUpdated 26 Oct 2026

$110Mraised across 2 rounds since 2014, from 2 sources

$70MSeries A$40MSeries B
Latest round
Series B, $40MAug 2024
Biggest round
$70MSeries A · Mar 2014
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201420162018202020222024
$70MSeries A$40MSeries B
First round
Series A, $70M
Mar 2014
Biggest round
$70M
Series A · Mar 2014
Between rounds
10.4 years
from the last two

The rounds

  1. Aug 2024
    Series B$40M2 new

    Source recordedSEC filing: $32M sold, first sale Mar 2023

  2. Mar 2014
    Series A$70M4 new

    From a historical funding record

Founders and team

From Human Longevity's own website: 2 on the team.

  • Women's Health Internal MedicinePresident & Chief Medical Officer
  • Cardiology Internal MedicineChief of Cardiology

AdvisersRadiology Genomics

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Draper Fisher Jurvetson (DFJ)Investment firm1round
Amino CapitalAccelerator1round
Illumina VenturesVC firm1round
IlluminaCompany1round
Bryan JohnsonAngel1round
Tan Sri Lim Kok Thayno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Human Longevity as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

BroadOak Capital PartnersVC firmPer its own site
Emerging Technology PartnersVC firmPer its own site
MRTNZ VenturesAngelPer its own site

Quick answers about Human Longevity

Who invested in Human Longevity?

Human Longevity's investors include Draper Fisher Jurvetson (DFJ), Amino Capital, Illumina Ventures, Illumina and Bryan Johnson, and 1 more on record.

How much has Human Longevity raised?

Human Longevity has raised $110M across 2 rounds since 2014.

When did Human Longevity last raise?

Human Longevity's most recent round was a Series B of $40M in Aug 2024.

What was Human Longevity's biggest round?

Human Longevity's largest round on record is $70M (Series A), in Mar 2014.

Who backed Human Longevity first?

Human Longevity's first round on record, in Mar 2014, was backed by Draper Fisher Jurvetson (DFJ), Illumina and Bryan Johnson and 1 others.

What stage is Human Longevity at?

Human Longevity's latest named round is a Series B, in Aug 2024.

Where is Human Longevity based?

Human Longevity is based in the United States.

Companies like Human Longevity

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.